Treatment of Ostial Right Coronary Artery Narrowings: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry

Yaniv Levi1, Ofer Kobo1, Majdi Halabi2

  • 1Department of Cardiology, Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.

Insights

Current drug-eluting stents (DES) show feasible treatment for right coronary artery (RCA) aorto-ostial (AO) lesions, with similar target lesion failure (TLF) rates. However, increased risks of target vessel revascularization and stent thrombosis were observed in RCA-AO stenting.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Previous treatments for right coronary artery (RCA) aorto-ostial (AO) lesions using bare-metal stents and first-generation drug-eluting stents (DES) were linked to poorer patient outcomes.
  • Current-generation DES offer potential improvements for complex coronary interventions.

Purpose of the Study:

  • To evaluate the clinical outcomes of stenting RCA-AO lesions using current-generation DES.
  • To compare the efficacy and safety of RCA-AO stenting versus proximal RCA stenting.

Main Methods:

  • The e-ULTIMASTER registry, a large, multicontinental study, included 37,198 patients undergoing percutaneous coronary intervention (PCI).
  • A cohort of 4775 patients received the Ultimaster stent for ostial and proximal RCA PCI.
  • The primary endpoint was 1-year target lesion failure (TLF), defined as cardiac death, target vessel myocardial infarction, or clinically indicated target lesion revascularization.

Main Results:

  • A comparison between 591 RCA-AO PCI patients and 4184 proximal RCA PCI patients revealed that the RCA-AO group had more comorbidities and complex coronary anatomy.
  • After propensity matching, TLF rates were similar (4.49% vs. 3.00%, P=.06).
  • However, RCA-AO stenting was associated with significantly higher rates of target vessel revascularization (3.29% vs. 1.90%, P=.03) and stent thrombosis (1.23% vs. 0.42%, P=.01) compared to proximal RCA stenting.

Conclusions:

  • Percutaneous coronary intervention for RCA-AO lesions using current-generation DES is technically feasible.
  • While overall target lesion failure rates are comparable to proximal RCA stenting, there is an elevated risk of target vessel revascularization and stent thrombosis in RCA-AO lesions.
Abstract

Related Concept Videos

Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...